As Peers Fall To Jaw-dropping Valuations And Sell-off, India's Zydus Cadila Bets On JV To Co-exist
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Large companies with well-oiled manufacturing skills and marketing networks in the growing Indian market have demonstrated their attractiveness as buyout targets for multinational companies, but analysts suggest that there could also be a significant interest developing from both sides of the spectrum in signing up proportionately profitable joint ventures for building strong manufacturing assets